Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NSC 601316

Known as: NSC-601316 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data the… Expand
Is this relevant?
2004
2004
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
Is this relevant?
1997
1997
This study reports on the biodistribution and metabolism of the 11C-labeled novel antitumor agent N-[2-(dimethylamino)ethyl… Expand
  • table I
  • figure 2
  • figure 3
  • figure 4
  • table 2
Is this relevant?
1994
1994
Several drugs with structural similarities to SKF-525A were tested for their ability to inhibit rat liver aldehyde oxidase using… Expand
Is this relevant?
1993
1993
Oxidation of the experimental anti-tumour agent N-[(2'-dimethylamino)ethyl]acridine-4-carboxamide (AC; NSC 601316; acridine… Expand
Is this relevant?
1991
1991
The acridine antitumor agent N-[2'-(dimethylamino)ethyl]acridine-4-carboxamide (AC; NSC 601316; acridine carboxamide) is oxidized… Expand
Is this relevant?
1990
1990
(N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide (acridine carboxamide; NSC 601316) is an acridine-derived experimental… Expand
Is this relevant?
1989
1989
N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide (AC; NSC 601316) is a chemically novel antitumour agent which is thought to… Expand
Is this relevant?
1988
1988
N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide (NSC 601316) is a DNA intercalating experimental antitumour agent which is… Expand
Is this relevant?